Skip to main content

Many Heart Failure Patients Do Not See a Cardiologist Annually

Medically reviewed by Carmen Pope, BPharm. Last updated on May 22, 2025.

By Elana Gotkine HealthDay Reporter

THURSDAY, May 22, 2025 -- About 40 percent of patients with heart failure diagnosis do not see a cardiologist annually, according to a study published online May 18 in the European Heart Journal.

Guillaume Baudry, M.D., Ph.D., from the Université de Lorraine in Nancy, France, and colleagues described prognosis and management across different strata using simple criteria in a nationwide cohort study. A total of 655,919 patients were classified into four groups: heart failure hospitalization (HFH) within the past year (HFH≤1y), HFH one to five years ago (HFH>1y), not hospitalized using loop diuretics (NoHFH/LD+), and not hospitalized without loop diuretics (NoHFH/LD−).

The researchers found that one-year all-cause mortality risk was 15.9 percent, varying from 8.0 to 25.0 percent for NoHFH/LD− and HFH≤1y, respectively. Compared with NoHFH/LD−, mortality risk was 1.61-, 1.83-, and 2.32-fold higher for NoHFH/LD+, HFH>1y, and HFH≤1y, respectively. Cardiology consultation rates were similar across groups during the first year of follow-up, with 40 percent of patients lacking an annual visit. Across all groups, a single cardiology visit in the previous year was associated with a 6 to 9 percent absolute reduction in one-year all-cause mortality. To prevent one modeled death, the number needed to consult was 11 to 16. Greater benefit was seen for additional visits with increasing heart failure severity. To minimize the number of deaths without increasing the total number of consultations, the optimal follow-up was one, two to three, and four annual visits for NoHFH/LD−, NoHFH/LD+ and HFH>1y, and HFH≤1y, respectively.

"Cardiology follow-up is essential for all patients with HF, while risk stratification based on loop diuretic use and HFH helps identify those who would benefit from more frequent consultations," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Pulmonary Embolism More Common in Children Than Previously Thought

THURSDAY, May 22, 2025 -- Pulmonary embolism (PE) is more common in children than previously thought, according to a study presented at the American Thoracic Society 2025...

Half of Youth-Serving Clinicians Screen for Substance Use Disorder at Every Well Visit

THURSDAY, May 22, 2025 -- Just over half of youth-serving clinicians report that they routinely screen adolescents for substance use disorders (SUDs) at every well visit...

Pediatric Magnet Ingestion Rates Still High

THURSDAY, May 22, 2025 -- Global pediatric magnet ingestion rates remain high and incidence has increased, despite the implementation of national policies, according to a review...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.